SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 7.93 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 6.60 |
| Book Value / Share | 0.91 |
| Price / Book | n/a |
| NCAV ($M) | 6.60 |
| NCAV / Share | 0.91 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.13 |
| Return on Equity (ROE) | 0.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.98 |
| Current Ratio | 7.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.54 |
| Assets | 7.54 |
| Liabilities | 0.95 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.79 |
| Net Income | 1.04 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.44 |
| Cash from Investing | 3.52 |
| Cash from Financing | -0.16 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| EGRX – Eagle Pharmaceuticals, Inc. | ELOX – Eloxx Pharmaceuticals, Inc. |
| ELTP – Elite Pharmaceuticals, Inc. | EMMA – Emmaus Life Sciences, Inc. |
| ENZB – Enzo Biochem, Inc. |
Financial data and stock pages provided by
Fintel.io